Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Completed

Looking for future studies?

Key information

Conditions

Acute Myocardial Infarction Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Synergy Cardiovascular Research Center, Rajkot, India

Who can participate

Only the study team can determine whether someone qualifies for participation.

Age 18-85 years
Index STEMI
Coronary angiogram with Primary coronary intervention
No contraindications for Cardiac MRI

Treatment and study plan

Primary outcomes

Prevalence of Ventricular Arrhytmia

Time frame: 24 hours

Prevalence of Premature Ventricular Contractions (PVCs), Non-Sustained Ventricular Tachycardia (NSVT), and Ventricular Tachycardia/Ventricular Fibrillation (VT/VF) detected by post-PCI Holter monitoring.

Sponsors and collaborators

Lead sponsor

Rohan Dharmakumar

Other

Registry information

Official study title

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Acronym: MIRON-RHYTHM

Important dates

Study start: 2022
Primary completion: 2024
Study completion: 2025
First posted: Sep 25, 2024
Registry last updated: Mar 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed